Advanced glycation end product homeostasis: Exogenous oxidants and innate defenses

Annals of the New York Academy of Sciences

Volumn 1126, Issue , 2008, Pages 46-52

  Vlassara, Helen ^a   Uribarri, Jaime ^a   Cai, Weijing ^a   Striker, Gary ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

AGE receptor 1; Caloric restriction; Dietary AGE restriction; Oxidant stress; p66 shc; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; OXIDIZING AGENT;

AGING; CALORIC RESTRICTION; CONFERENCE PAPER; CORRELATION ANALYSIS; DIABETES MELLITUS; DIET; FOOD INTAKE; HOMEOSTASIS; HUMAN; IMMUNITY; KIDNEY FAILURE; KIDNEY FIBROSIS; LIFESPAN; MULTIPLE ORGAN FAILURE; NONHUMAN; OXIDATIVE STRESS;

MUS;

EID: 42549089560     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1433.055     Document Type: Conference Paper

References (27)

1. 1 Vlassara, H. 2005. Advanced glycation in health and disease. Role of modern environment. Ann. N.Y. Acad. Sci. 1043: 452–460.
2. 2 Huebschmann, A.G., J.G. Regensteiner, H. Vlassara & J.E.B. Reusch. 2006. Diabetes and advanced glycoxidation end products. Diabetes Care 29: 1420–1432.
3. 3 Cai, W., C.J. He, L. Zhu, et al. 2007. Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet. Association with increased AGER1 expression. Am. J. Pathol. 170: 1893–1902.
4. 4 Abordo, E.A., H.S. Minhas & P.J. Thornalley. 1999. Accumulation of alpha‐oxoaldehydes during oxidative stress: a role in cytotoxicity. Biochem. Pharmacol. 58: 641–648.
5. 5 Vander Jagt, D.L. & L.A. Hunsaker. 2003. Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase‐I, betaine aldehyde dehydrogenase and 2‐oxoaldehyde dehydrogenase. Chem. Biol. Interact. 143/144: 341–351.
6. 6 Liu, H., F. Zheng, Qi Cao, et al. 2006. Amelioration of oxidant stress by the defensin, lysozyme. Am. J. Physiol. 290: E824–E832.
7. 7 Lu, C., J.C. He, W. Cai, et al. 2004. AGE‐Receptor‐1 is a negative regulator of the inflammatory response to advanced glycation endproducts in mesangial cells. Proc. Natl. Acad. Sci. USA 101: 11767–11772.
8. 8 Schmidt, A.M., O. Hori, J. Brett, et al. 1994. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler. Thromb. 14: 1521–1528.
9. 9 Cai, W., J.C. He, L. Zhu & H. Vlassara. 2006. Advanced glycation end products (AGE) receptor‐1 suppresses cell oxidant stress and activation signaling via EGF‐Receptor. Proc. Natl. Acad. Sci. USA 103: 13801–13806.
10. 10 He, C., T. Koschinsky, C. Buenting & H. Vlassara. 2001. Presence of diabetic complications in Type 1 diabetic patients correlates with low expression of mononuclear AGE‐receptor‐1 and elevated serum AGE. Mol. Med. 7: 159–168.
11. 11 Cai, W., J.C. He, L. Zhu, et al. 2007. Oral glycotoxins induce oxidant stress, insulin resistance, cardiovascular/renal disease and a shortened lifespan in calorie‐restricted C57BL6 mice. In press.
12. 12 Koschinsky, T., C.J. He, T. Mitsuhashi, et al. 1997. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc. Natl. Acad. Sci. USA 94: 6474–6479.
13. 13 Uribarri, J., M. Peppa, W. Cai, et al. 2003. Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. J. Am. Soc. Nephrol. 14: 728–731.
14. 14 Coresh, J., B.C. Astor, E. Greene, et al. 2003. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Disease 41: 1–12.
15. 15 Goldberg, T., W. Cai, M. Peppa, et al. 2004. Advanced glycoxidation end products in commonly consumed foods. J. Am. Diet. Assoc. 104: 1287–1291.
16. 16 Vlassara, H., W. Cai, J. Crandall, et al. 2002. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc. Natl. Acad. Sci. USA 99: 15596–15601.
17. 17 Uribarri, J., W. Cai, M. Peppa, et al. 2007. Circulating glycotoxins and dietary AGEs; two links to inflammatory response, oxidative stress and aging. J. Am. Gerontol. Sci. 62: 427–433.
18. 18 Peppa, M., C. He, C. Hattori, et al. 2003. Fetal or neonatal low‐glycotoxin environment prevents autoimmune diabetes in NOD mice. Diabetes 52: 1441–1448.
19. 19 Hofmann, S.M., H.J. Dong, Z. Li, et al. 2002. Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes 51: 2082–2089.
20. 20 Zheng, F., C. He, W. Cai, et al. 2002. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. Diabetes Metab. Res. Rev. 18: 224–237.
21. 21 Lin, R.Y., E.D. Reis, A.T. Dore, et al. 2002. Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice. Atherosclerosis 163: 303–311.
22. 22 Peppa, M., P. Brem, J. Ehrlich, et al. 2003. Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes 52: 2805–2813.
23. 23 Uribarri, J., A. Stirban, D. Sander, et al. 2007. Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects. Diabetes Care 30: 2579–2582.
24. 24 Negrean, M., A. Stirban, B. Stratmann, et al. 2007. Effects of low‐ and high‐advanced glycation endproduct meals on macro‐ and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am. J. Clin. Nutr. 85: 1236–1243.
25. 25 Stirban, A., M. Negrean, A. Stirban, et al. 2006. Benfotiamine prevents macro‐ and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 29: 2064–2071.
26. 26 Couillard, C., G. Ruel, W.R. Archer, et al. 2005. Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J. Clin. Endocrinol. Metab 90: 6454–6459.
27. 27 Keaney, J.F., M.G. Larson, R.S. Vasan, et al. 2003. Obesity and systemic oxidative stress. Clinical correlates of oxidative stress in the Framingham study. Arterioscler. Thromb. Vasc. Biol. 23: 434–439.